111 Inc (YI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, 111 Inc (YI) has a cash flow conversion efficiency ratio of 0.174x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($38.08 Million) by net assets ($218.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
111 Inc - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how 111 Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 111 Inc (YI) financial obligations for a breakdown of total debt and financial obligations.
111 Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of 111 Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Haiwan International Development Co Ltd
TWO:3252
|
0.019x |
|
Reviva Pharmaceuticals Holdings Inc.
NASDAQ:RVPH
|
-1.229x |
|
Allwin Telecommunication Co Ltd
SHE:002231
|
-0.069x |
|
Unite Group PLC
LSE:UTG
|
0.019x |
|
Trajectory Alpha Acquisition Corp
NYSE:TCOA
|
-0.004x |
|
Yong Shun Chemical Co Ltd
TWO:4711
|
0.022x |
|
Atec T& Co. Ltd
KQ:224110
|
-0.026x |
|
Heartbeam Inc
NASDAQ:BEAT
|
-7.783x |
Annual Cash Flow Conversion Efficiency for 111 Inc (2016–2024)
The table below shows the annual cash flow conversion efficiency of 111 Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see 111 Inc (YI) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $380.76 Million | $263.02 Million | 0.691x | +142.64% |
| 2023-12-31 | $276.10 Million | $-447.24 Million | -1.620x | -4435.40% |
| 2022-12-31 | $648.24 Million | $-23.15 Million | -0.036x | +95.28% |
| 2021-12-31 | $848.71 Million | $-641.94 Million | -0.756x | -761.87% |
| 2020-12-31 | $1.33 Billion | $-116.78 Million | -0.088x | +86.69% |
| 2019-12-31 | $773.92 Million | $-510.19 Million | -0.659x | -135.19% |
| 2018-12-31 | $1.22 Billion | $-343.02 Million | -0.280x | +56.27% |
| 2017-12-31 | $318.82 Million | $-204.37 Million | -0.641x | +5.07% |
| 2016-12-31 | $575.52 Million | $-388.65 Million | -0.675x | -- |
About 111 Inc
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education,… Read more